Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity and Capital Stock

v3.20.1
Shareholders' Equity and Capital Stock
3 Months Ended
Mar. 31, 2020
Shareholders' Equity and Capital Stock [Abstract]  
Shareholders' Equity and Capital Stock

13.Shareholders’ Equity and Capital Stock

 

Stock options

 

In 2005, the Company’s Board of Directors approved the adoption of the Company's stock option plan (the “Option Plan”). The Option Plan was most recently approved by the shareholders on May 18, 2017. Eligible participants under the Option Plan include directors, officers, employees and consultants of the Company. Under the terms of the Option Plan grants of options will vest over a three-year period: 33.3% on the first anniversary, 33.3% on the second anniversary, and 33.4% on the third anniversary of the grant. The term of options is five years.

 

Activity with respect to stock options is summarized as follows:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

average

 

 

 

Options

 

exercise price

 

 

 

#

 

$

 

 

 

 

 

 

Balance, December 31, 2019

 

 

11,076,583

 

0.64

 

 

 

 

 

 

Forfeited

 

 

(23,889)

 

0.61

 

 

 

 

 

 

Outstanding, March 31, 2020

 

 

11,052,694

 

0.64

 

The exercise price of a new grant is set at the closing price for the shares on the Toronto Stock Exchange (TSX) on the trading day immediately preceding the grant date so there is no intrinsic value as of the date of grant. The fair value of options vested during the three months ended March 31, 2020 was less than  $0.1 million.

 

As of March 31, 2020, outstanding stock options are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding

 

Options exercisable

 

 

 

 

 

 

Weighted-

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

average

 

 

 

 

 

average

 

 

 

 

 

 

 

 

remaining

 

Aggregate

 

 

 

remaining

 

Aggregate

 

 

Exercise

 

Number

 

contractual

 

intrinsic

 

Number

 

contractual

 

intrinsic

 

 

price

 

of options

 

life (years)

 

value

 

of options

 

life (years)

 

value

 

Expiry

$

 

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.80

 

200,000

 

0.2

 

 -

 

200,000

 

0.4

 

 -

 

29-May-20

0.61

 

516,902

 

0.4

 

 -

 

516,902

 

0.6

 

 -

 

17-Aug-20

0.56

 

897,508

 

0.7

 

 -

 

897,508

 

0.9

 

 -

 

11-Dec-20

0.51

 

2,337,434

 

1.7

 

 -

 

2,337,434

 

2.0

 

 -

 

16-Dec-21

0.72

 

300,000

 

1.9

 

 -

 

300,000

 

2.2

 

 -

 

02-Mar-22

0.51

 

200,000

 

2.4

 

 -

 

132,000

 

2.7

 

 -

 

07-Sep-22

0.63

 

1,769,411

 

2.7

 

 -

 

1,187,174

 

3.0

 

 -

 

15-Dec-22

0.54

 

200,000

 

3.0

 

 -

 

133,333

 

3.2

 

 -

 

30-Mar-23

0.66

 

976,259

 

3.4

 

 -

 

339,859

 

3.6

 

 -

 

20-Aug-23

0.64

 

826,683

 

3.7

 

 -

 

278,351

 

4.0

 

 -

 

14-Dec-23

0.56

 

2,828,497

 

4.6

 

 -

 

 -

 

 -

 

 -

 

05-Nov-24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.64

 

11,052,694

 

2.8

 

 -

 

6,322,561

 

2.1

 

 -

 

 

 

The aggregate intrinsic value of the options in the preceding table represents the total pre-tax intrinsic value for stock options with an exercise price less than the Company’s TSX closing stock price of Cdn$0.56 as of the last trading day in the period ended March 31, 2020, that would have been received by the option holders had they exercised their options as of that date. There were no options issued or exercisable that were in the money at March 31, 2020.

 

We elect to estimate the number of awards expected to vest in lieu of accounting for forfeitures when they occur.   

 

Restricted share units

 

On June 24, 2010, the Company’s shareholders approved the adoption of the Company’s restricted share unit plan (the “RSU Plan”). The RSU Plan was approved by our shareholders most recently on May 2, 2019.

 

Eligible participants under the RSU Plan include directors and employees of the Company. RSUs in a grant redeem on the second anniversary of the grant. Upon RSU vesting, the holder of an RSU will receive one Common Share, for no additional consideration, for each RSU held.

 

Activity with respect to RSUs is summarized as follows:

 

 

 

 

 

 

 

 

 

 

Number

 

Weighted

 

 

 

of

 

average grant

 

 

 

RSUs

 

date fair value

Balance, December 31, 2019

 

 

1,155,928

 

0.65

 

 

 

 

 

 

Forfeited

 

 

(5,973)

 

0.68

 

 

 

 

 

 

Outstanding, March 31, 2020

 

 

1,149,955

 

0.59

 

As of March 31, 2020, outstanding RSUs are as follows:

 

 

 

 

 

 

 

 

 

 

Number of

 

Remaining

 

Aggregate

 

 

outstanding

 

life

 

intrinsic

Grant date

 

RSUs

 

(years)

 

value

 

 

 

 

 

 

$

August 20, 2018

 

225,774

 

0.39

 

93

December 14, 2018

 

217,048

 

0.71

 

89

November 5, 2019

 

707,133

 

1.60

 

290

 

 

 

 

 

 

 

 

 

1,149,955

 

1.19

 

472

 

As of September 30, 2019, one of our officers retired. Under the terms of our RSU Plan, his 54,431 outstanding RSUs automatically vested. On December 15, 2019, 28,686 RSUs were redeemed for Common Shares. The balance of his RSUs will be redeemed for cash or stock at the compensation committee’s discretion in conjunction with the scheduled redemptions  of those grants.   

 

Warrants

 

On September 25, 2018, the Company issued 13,062,878 warrants to purchase 6,531,439 of our Common Shares at $1.00 per full share (see note 12). The following represents warrant activity during the period ended March 31, 2020:

 

 

 

 

 

 

 

 

 

Number

Number of

 

 

 

 

of

shares to be issued

 

Per share

 

 

warrants

upon exercise

 

exercise price

Outstanding, December 31, 2019

 

13,062,878

6,531,439

 

1.00

 

 

 

 

 

 

Outstanding, March 31, 2020

 

13,062,878

6,531,439

 

1.00

 

 

As of March 31, 2020, outstanding warrants are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

Exercise

 

Number

 

contractual

 

Intrinsic

 

 

price

 

of warrants

 

life (years)

 

Value

 

Expiry

$

 

 

 

 

 

$

 

 

1.00

 

13,062,878

 

1.5

 

 -

 

25-Sep-21

 

Share-based compensation expense

 

Share-based compensation expense was $0.2 million for the three months ended March 31, 2020 and $0.2 million for the three months ended March 31, 2019.

 

As of March 31, 2020, there was approximately $1.3 million of total unrecognized compensation expense (net of estimated pre-vesting forfeitures) related to unvested share-based compensation arrangements granted under the Option Plan and $0.5 million under the RSU Plan. The expenses are expected to be recognized over a weighted-average period of 2.1 years and 1.4 years, respectively.

 

No cash was received from the exercise of stock options for the three months ended March 31, 2020 or March 31, 2019.

 

Fair value calculations

 

The initial fair value of options and RSUs granted is determined using the Black-Scholes option pricing model for options and the intrinsic pricing model for RSUs. There were no options or RSUs granted during the three months ended March 31, 2020 and March 31, 2019. We have used assumptions for the mark to market calculations related to the warrant liability.

 

 

The Company estimates expected volatility using daily historical trading data of the Company’s Common Shares, because this is recognized as a valid method used to predict future volatility. The risk-free interest rates are determined by reference to Canadian Treasury Note constant maturities that approximate the expected option term. The Company has never paid dividends and currently has no plans to do so.

 

Share-based compensation expense is recognized net of estimated pre-vesting forfeitures, which results in recognition of expense on options that are ultimately expected to vest over the expected option term. Forfeitures were estimated using actual historical forfeiture experience.